However, little data are available to describe whether NEDD4-2-mediated GRIA1 ubiquitination is changed, and this alteration is relevant to the generation of refractory seizures to AMPAR antagonists in a chronic epilepsy model. This evidence concerns the gene NEDD4L and epilepsy.